News
Xspray Pharma enters license agreement with Handa Therapeutics to commercialize dasatinib product in US & selected Asian markets: Sweden Thursday, August 14, 2025, 11:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback